Recognition of the importance of IDH1/2 mutations in progression of diffuse gliomas advanced our understanding of glioma biology, however the full impact of a state of DNA and histone hypermethylation on gene regulatory networks and cell functions is less clear. This evidence concerns the gene IDH1 and central nervous system cancer.